Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sun Pharmaceutical Industries is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company globally. The company provides a diverse portfolio of over 2,000 molecules across therapeutic areas such as dermatology, ophthalmology, oncology, and psychiatry. While historically focused on generics, Sun Pharma has successfully pivoted toward a specialty-driven model with blockbuster products like Ilumya for psoriasis and Winlevi for acne. Operating more than 40 manufacturing facilities across six continents, the company maintains a robust R&D pipeline of novel specialty molecules and complex generics. Sun Pharma serves patients in over 100 countries and is a dominant player in the U.S. dermatology and generic markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sun Products.